Literature DB >> 17534148

TGF-beta receptor I conditional knockout mice develop spontaneous squamous cell carcinoma.

Yasuyuki Honjo1, Yansong Bian, Koji Kawakami, Alfredo Molinolo, Glenn Longenecker, Ramanamurthy Boppana, Jonas Larsson, Stefan Karlsson, J Silvio Gutkind, Raj K Puri, Ashok B Kulkarni.   

Abstract

We generated a mouse model with a conditional deletion of TGF-beta signaling in the neurons by crossing TGF-beta receptor I (TbetaRI) floxed mice with neurofilament-H (NF-H) Cre mice. 35% of F1 conditional knockout (COKO) mice developed spontaneous squamous cell carcinomas (SCCs) in periorbital and/or perianal regions. Transplantation of these tumors into athymic nude mice resulted in 62% tumorigenicity. To determine whether evasion of the immune response plays any role in this tumorigenesis, we analyzed the expression levels of receptors for interleukin-13 (mIL-13R), a key negative regulator of tumor immunosurveillance, and found that 33% of COKO tumors expressed the IL-13R alpha2 chain. Primary cultures of the SCCs expressing IL-13R alpha2 were sensitive to the cytotoxic effect of IL-13R-directed cytotoxin treatment. This is the first demonstration that loss of TbetaRI can lead to spontaneous tumor formation. These mice can serve as a unique mouse model of SCC to evaluate the tumorigenicity and effect of anti-cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534148     DOI: 10.4161/cc.6.11.4268

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  21 in total

Review 1.  Dysregulated molecular networks in head and neck carcinogenesis.

Authors:  Alfredo A Molinolo; Panomwat Amornphimoltham; Cristiane H Squarize; Rogerio M Castilho; Vyomesh Patel; J Silvio Gutkind
Journal:  Oral Oncol       Date:  2008-09-19       Impact factor: 5.337

Review 2.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

Review 3.  TGFβ signaling in head and neck squamous cell carcinoma.

Authors:  R A White; S P Malkoski; X-J Wang
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

Review 4.  Epithelial stem cells, wound healing and cancer.

Authors:  Esther N Arwert; Esther Hoste; Fiona M Watt
Journal:  Nat Rev Cancer       Date:  2012-02-24       Impact factor: 60.716

Review 5.  Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma.

Authors:  Fanglong Wu; Kelsey J Weigel; Hongmei Zhou; Xiao-Jing Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2018-01-01       Impact factor: 3.848

6.  Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma.

Authors:  Lei Wu; Guang-Tao Yu; Wei-Wei Deng; Liang Mao; Lei-Lei Yang; Si-Rui Ma; Lin-Lin Bu; Ashok B Kulkarni; Wen-Feng Zhang; Lu Zhang; Zhi-Jun Sun
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

7.  Serial orthotopic transplantation of epithelial tumors in single-cell suspension.

Authors:  Heather A McCauley; Géraldine Guasch
Journal:  Methods Mol Biol       Date:  2013

8.  Proceedings of the 2018 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Vinicius Carreira; Caralyn S Labriola; Debabrata Mahapatra; Sean R McKeag; Matthias Rinke; Cynthia Shackelford; Bhanu Singh; Ashley Talley; Shannon M Wallace; Lyn M Wancket; Cynthia J Willson
Journal:  Toxicol Pathol       Date:  2018-10-03       Impact factor: 1.902

9.  Smad4-dependent desmoglein-4 expression contributes to hair follicle integrity.

Authors:  Philip Owens; Hisham Bazzi; Erin Engelking; Gangwen Han; Angela M Christiano; Xiao-Jing Wang
Journal:  Dev Biol       Date:  2008-07-26       Impact factor: 3.582

10.  Mice with disrupted TGFbeta signaling have normal cerebella development, but exhibit facial dysmorphogenesis and strain-dependent deficits in their body wall.

Authors:  Yoshiya Asano; Kyoko Koishi; Tony Frugier; Ian S McLennan
Journal:  Cell Mol Neurobiol       Date:  2009-02-13       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.